Information Provided By:
Fly News Breaks for July 10, 2019
HOLX
Jul 10, 2019 | 05:37 EDT
Piper Jaffray analyst William Quirk says his CynoSure checks are "mixed" with available lasers increasing on eBay and several other third party websites, but with "stable higher value" SculpSure systems and increasing laser prices. This business line is showing more signs of stabilization, Quirk tells investors in a research note. He believes Hologic's core Breast Health and Diagnostics businesses will again have the largest incremental impact on potential upside in the quarter. The company's shares continue to trade at a "substantial discount" to peers, says Quirk, who keeps an Overweight rating on the name with a $49 price target.
News For HOLX From the Last 2 Days
There are no results for your query HOLX